scispace - formally typeset
Search or ask a question
Institution

University of Perugia

EducationPerugia, Umbria, Italy
About: University of Perugia is a education organization based out in Perugia, Umbria, Italy. It is known for research contribution in the topics: Population & Large Hadron Collider. The organization has 13365 authors who have published 39516 publications receiving 1265601 citations. The organization is also known as: Universitá degli Studi di Perugia & Universita degli Studi di Perugia.


Papers
More filters
Journal ArticleDOI
TL;DR: An overview of the main results presented in literature on this topic, focusing the attention on the fibres properties in terms of physical and chemical structure, thermal and mechanical properties are also presented.
Abstract: Natural fibre-based composites have been intensely studied in the last years due to their specific properties and their clearly positive environmental impact. Other advantages of using vegetable fibres are related to their economical production and processing, their safe handling and working conditions. Therefore, lignocellulosic natural fibres constitute an interesting alternative to traditional synthetic fibres in composite materials. This work is intended to present an overview of the main results presented in literature on this topic, focusing the attention on the fibres properties in terms of physical and chemical structure, thermal and mechanical properties. Some aspects related to the production of vegetable fibres for composites are also presented.

341 citations

Journal ArticleDOI
01 May 2010-Gut
TL;DR: A new IDO-dependent pathway leading to acquisition of tolerogenic functions in mucosal CD103-expressing DCs is identified, indicating IDO as a possible therapeutic target for gut disorders.
Abstract: Objective CD103 + gut dendritic cells (DCs) have been shown to be required for de novo conversion of adaptive T regulatory (Treg) cells. Indoleamine 2,3-dioxygenase (IDO) is an enzyme involved in tryptophan catabolism that is expressed by DCs isolated from tumour-draining lymph nodes. IDO-expressing DCs sustain and differentiate Tregs. The aim of this study was to investigate the expression and the possible physiological role of IDO in the tolerogenic properties of intestinal DCs. Design The expression level of IDO in CD103 + and CD103 − DCs was analysed by qRT-PCR, western blot and immunofluorescence. CD103 + and CD103 − DCs were sorted from mesenteric lymph nodes (MLNs) and the small intestinal lamina propria, and the role of IDO in the conversion of Tregs and Th effector cell development was evaluated via specific inhibition or gene deletion. Oral tolerance, experimental colitis and T cell differentiation in vivo were assessed upon IDO inactivation. Results We show that, primarily, CD103 + but not CD103 − gut DCs express IDO whose inhibition results in reduced CD4 + Foxp3 + T regulatory cell conversion and enhanced T cell proliferation. When IDO was inhibited or genetically deleted there was an increase in Th1 and Th17 differentiation both in vitro and in vivo. Finally, in vivo IDO blockade affected the development of Tregs specific for orally administered antigens, impaired oral tolerance induction and exacerbated colitis. Conclusions We identified a new IDO-dependent pathway leading to acquisition of tolerogenic functions in mucosal CD103-expressing DCs, indicating IDO as a possible therapeutic target for gut disorders.

340 citations

Journal ArticleDOI
TL;DR: A remarkable functional plasticity of DC is found in response to the different forms of the fungus, as pulmonary DC were able to internalize conidia and hyphae of A. fumigatus through distinct phagocytic mechanisms and recognition receptors.
Abstract: Aspergilli are respiratory pathogens and pulmonary infections are usually acquired through the inhalation of conidia, able to reach small airways and the alveolar space where the impaired host defense mechanisms allow hyphal germination and subsequent tissue invasion. The invasive pulmonary aspergillosis is the most common manifestation of Aspergillus fumigatus infection in immunocompromised patients and is characterized by hyphal invasion and destruction of pulmonary tissue. A Th1/Th2 dysregulation and a switch to a Th2 immune response may contribute to the development and unfavorable outcome of invasive pulmonary aspergillosis. Dendritic cells (DC) have a primary role in surveillance for pathogens at the mucosal surfaces and are recognized as the initiators of immune responses to them. In the present study, we assessed the functional activity of pulmonary DC in response to A. fumigatus conidia and hyphae, both in vitro and in vivo. We analyzed mechanisms and receptors for phagocytosis by DC as well as DC migration, maturation, and Th priming in vivo upon exposure to either form of the fungus. We found a remarkable functional plasticity of DC in response to the different forms of the fungus, as pulmonary DC were able to: 1) internalize conidia and hyphae of A. fumigatus through distinct phagocytic mechanisms and recognition receptors; 2) discriminate between the different forms in terms of cytokine production; 3) undergo functional maturation upon migration to the draining lymph nodes and spleens; and 4) instruct local and peripheral Th cell reactivity to the fungus.

340 citations

Journal ArticleDOI
TL;DR: The study results suggest an excellent efficacy but also the necessity of caution in the prescription of linezolid, and the proportion of adverse events was significantly higher when the lineZolid daily dosage exceeded 600 mg.
Abstract: Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety and tolerability of linezolid-containing regimes based on individual data analysis. 12 studies (11 countries from three continents) reporting complete information on safety, tolerability, efficacy of linezolid-containing regimes in treating MDR-TB cases were identified based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Meta-analysis was performed using the individual data of 121 patients with a definite treatment outcome (cure, completion, death or failure). Most MDR-TB cases achieved sputum smear (86 (92.5%) out of 93) and culture (100 (93.5%) out of 107) conversion after treatment with individualised regimens containing linezolid (median (inter-quartile range) times for smear and culture conversions were 43.5 (21-90) and 61 (29-119) days, respectively) and 99 (81.8%) out of 121 patients were successfully treated. No significant differences were detected in the subgroup efficacy analysis (daily linezolid dosage ≤ 600 mg versus >600 mg). Adverse events were observed in 63 (58.9%) out of 107 patients, of which 54 (68.4%) out of 79 were major adverse events that included anaemia (38.1%), peripheral neuropathy (47.1%), gastro-intestinal disorders (16.7%), optic neuritis (13.2%) and thrombocytopenia (11.8%). The proportion of adverse events was significantly higher when the linezolid daily dosage exceeded 600 mg. The study results suggest an excellent efficacy but also the necessity of caution in the prescription of linezolid.

340 citations

Journal ArticleDOI
TL;DR: Orally administered VSL#3 prevents autoimmune diabetes and induces immunomodulation by a reduction in insulitis severity, providing a sound rationale for future clinical trials of the primary prevention of type 1 diabetes by oral V SL#3 administration.
Abstract: Aims/hypothesis Recent observations suggest the involvement of the gastrointestinal tract in the pathogenesis of islet autoimmunity. Thus, the modulation of gut-associated lymphoid tissue may represent a means to affect the natural history of the disease. Oral administration of probiotic bacteria can modulate local and systemic immune responses; consequently, we investigated the effects of oral administration of the probiotic compound VSL#3 on the occurrence of diabetes in non-obese diabetic (NOD) mice.

340 citations


Authors

Showing all 13488 results

NameH-indexPapersCitations
Michael Grätzel2481423303599
Luigi Ferrucci1931601181199
Tobin J. Marks1591621111604
Johan Auwerx15865395779
Tony Pawson15042585196
Jack Hirsh14673486332
Alexander Belyaev1421895100796
R. L. McCarthy1411238115696
Harvey B Newman139159488308
Guido Tonelli138145897248
Elias Campo13576185160
Alberto Messineo134151196492
Franco Ligabue134140495389
Roberto Tenchini133139094541
R. Bartoldus132162497405
Network Information
Related Institutions (5)
University of Padua
114.8K papers, 3.6M citations

98% related

Sapienza University of Rome
155.4K papers, 4.3M citations

98% related

University of Bologna
115.1K papers, 3.4M citations

98% related

University of Milan
139.7K papers, 4.6M citations

97% related

University of Turin
77.9K papers, 2.4M citations

97% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023108
2022226
20212,487
20202,594
20192,362
20182,274